截至2025年9月2日15时，上海医药股价报18.60元，较前一交易日上涨0.59%。当日成交量为270569手，成交金额达5.03亿元，振幅1.68%。公司当前总市值为689.76亿元，市盈率为7.73倍。
上海医药是国内大型医药产业集团，业务覆盖医药研发与制造、分销与零售全产业链。公司主要产品包括化学药、生物药、中药和医疗器械等，在上海地区具有重要市场地位。
据公开信息显示，保险公司在2025年二季度新晋重仓上海医药，持仓总股数超过1亿股。这一数据反映出机构投资者对公司长期发展的关注。
资金流向方面，9月2日主力资金净流入2477.62万元，占流通市值比例为0.05%。近五个交易日主力资金累计净流出29075.15万元，占流通市值比例为0.56%。
风险提示：股市有风险，投资需谨慎。（本内容由AI生成，仅供参考，不构成投资建议。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.